Increased Pulmonary Embolism Risk WIth Rheumatoid Arthritis Drug Tofacitinib - The Cardiology Advisor

Increased Pulmonary Embolism Risk WIth Rheumatoid Arthritis Drug Tofacitinib  The Cardiology Advisor

Tofacitinib dosed at 10 mg twice daily was associated with an increased risk of pulmonary embolism and overall mortality in patients with rheumatoid arthritis.



Comments

Post a Comment

Popular posts from this blog

Celgene Corporation Announces POMALYST® Granted Breakthrough Therapy Designation from FDA for HIV-Positive and Negative Kaposi Sarcoma - Global Banking And Finance Review

Celgene Corporation Announces POMALYST® Granted Breakthrough Therapy Designation from FDA for HIV-Positive and Negative Kaposi Sarcoma    Global Banking And Finance Review Celgene Corporation (NASDAQ:CELG) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to ...
Read more